Millipore Sigma Vibrant Logo

MABN1839 Anti-Amyloid-β (oligomer) Antibody, clone F11G3

This Anti-Amyloid-β (oligomer) Antibody, clone F11G3 is validated for use in Western Blotting, Dot Blot, ELISA, Immunofluorescence, Immunoprecipitation for the detection of Amyloid-β.

Anti-Amyloid-β (oligomer) Antibody, clone F11G3 : のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。
Research Category: Neuroscience Research Sub-Category: Neurodegenerative Diseases Gene Symbol: APP, PRNP, PRP, MAPT, TAU, SNCA, TARDBP, TDP43 UniProt Number: P04156
View This Product on Sigma-Aldrich
MABN1839
100 μg  
価格を検索中…
価格が見つかりません
Minimum Quantity needs to be mulitiple of
Maximum Quantity is
弊社照会 詳細を表示　
値引
()
 
—
弊社照会
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      Special Offers［海外情報］

       

      お問合せください

      概要

      Replacement Information

      Special Offers［海外情報］

      100% Performance Guaranteed

      主要スペック表

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, MWB, DB, ELISA, IF, IPMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABN1839
      DescriptionAnti-Amyloid-β (oligomer) Antibody, clone F11G3
      Alternate Names
      • Amyloid beta oligomer
      • Abeta oligomer
      • alpha-synuclein oligomer,
      • alpha-syn oligomer
      • Prion protein oligomer
      • PrP oligomer
      • TAR DNA-binding protein 43 oligomer
      • TDP-43 oligomer
      • Tau oligomer
      Background InformationAccumulations of insoluble deposits/aggregates are the hallmarks of several neurodegenerative diseases. Deposits involving Aβ and tau proteins in Alzheimer's disease (AD), α-synuclein (α-syn) in Parkinson's disease (PD), prion protein (PrP) in prion diseases (PrD), TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia-TDP (FTLD-TDP) are well known examples. Evidence suggests that oligomers represent the more toxic species than fibrillar deposits in neurodegenerative conditions, such as AD, PD, and PrD. The number of Aβ deposits, for example, correlates poorly with disease progression, and many researchers consider them to be inert or even protective. Antibodies targeting beta-sheet oligomer conformations are being developed not only to study neurotoxic oligomers, but also for diagnostic and therapeutic purposes.
      References
      Product Information
      FormatPurified
      PresentationPurified mouse monoclonal IgMκ antibody in PBS without preservatives.
      Quality LevelMQ100
      Applications
      ApplicationThis Anti-Amyloid-β (oligomer) Antibody, clone F11G3 is validated for use in Western Blotting, Dot Blot, ELISA, Immunofluorescence, Immunoprecipitation for the detection of Amyloid-β.
      Key Applications
      • Western Blotting
      • Dot Blot
      • ELISA
      • Immunofluorescence
      • Immunoprecipitation
      Application NotesImmunofluorescence Analysis: A representative lot specifically detected amyloid beta-sheet oligomer immunoreactivity in paraffin-embedded brain sections from Alzheimer's diseased (AD), but not non-AD human brain by fluorescent immunohistochemistry (Courtesy of Dr. Rakez Kayed, University of Texas Medical Branch, Galveston, TX).

      Western Blotting Analysis: A representative lot detected Ataxin-1 oligomers in soluble cerebella extracts from Atxn1154Q/+, but not wild-type or Atxn-/-, mice (Lasagna-Reeves, C.A., et al. (2015). eLlife. 4:e07558).

      Western Blotting Analysis: A representative lot detected cellular beta-sheet oligomer immunoreactivity in HeLa cells transfected with the pathogenic (82Q), but not the non-pathogenic (30Q) form of polyQ Ataxin-1 in transfected Hela cells. Co-transfecting with the native Atxn-1 binding partner Capicua (CIC), but not the binding defective CIC W37A mutant, enhanced the oligomer formation (Lasagna-Reeves, C.A., et al. (2015). eLlife. 4:e07558).

      Western Blotting Analysis: A representative lot detected the highest extend of oligomers accumulation in the soluble cerebella extracts among the 28-week old Atxn1154Q/+ mice when compared with samples from 18-week old and 8-week old Atxn1154Q/+ mice, with the 8-week old mice bearing the least oligomer buildup (Lasagna-Reeves, C.A., et al. (2015). eLlife. 4:e07558).

      Western Blotting Analysis: A representative lot specifically detected oligomeric, but not monomeric or fibrillar, forms of Aβ42, α-Syn, PrP, and TDP-43 (Guerrero-Muñoz, M.J., et al. (2014). Neurobiol. Dis.71:14-23).

      App3/DB/ A representative lot specifically detected oligomeric, but not monomeric or fibrillar, forms of Aβ42, α-Syn, PrP, and TDP-43 (Guerrero-Muñoz, M.J., et al. (2014). Neurobiol. Dis.71:14-23).

      ELISA Analysis: A representative lot detected in vitro Aβ42, α-Syn, PrP, and TDP-43 oligomers formation with or without Aβ42 oligomer seeding (Guerrero-Muñoz, M.J., et al. (2014). Neurobiol. Dis.71:14-23).

      Immunofluorescence Analysis: A representative lot detected a positive correlation between the ATXN1 beta-sheet oligomer immunoreactivity and the degeneration progression in calbindin-positive Purkinje cells (PCs) by fluorescent immunohistochemistry using paraffin-embedded cerebellum sections from Atxn1154Q/+ mice (Lasagna-Reeves, C.A., et al. (2015). eLlife. 4:e07558).

      Immunofluorescence Analysis: A representative lot selectively detected beta-sheet oligomer immunoreactivity colocalized with those of Aβ, α-Syn, PrP, and TDP-43 in paraffin-embedded frontal cortex sections from Alzheimer's diseased brain by fluorescent immunohistochemistry. The beta-sheet oligomer immunoreactivity is not detected in non-AD brains and is distinct from the staining pattern obtained with Thioflavin S (Guerrero-Muñoz, M.J., et al. (2014). Neurobiol. Dis.71:14-23).

      Immunoprecipitation Analysis: A representative lot immunoprecipitated Ataxin-1 oligomers from the soluble cerebella extracts of Atxn1154Q/+, but not Atxn-/-, mice (Lasagna-Reeves, C.A., et al. (2015). eLlife. 4:e07558).

      Immunocytochemistry Analysis: A representative lot detected cellular beta-sheet oligomer immunoreactivity in HeLa cells transfected with the pathogenic polyQ Ataxin-1 mRFP fusion construct mRFP-ATXN1(82Q) by fluorescent immunocytochemistry. Co-transfecting with the N-terminal fragment of the Atxn-1 binding partner Capicua (CIC), but not the binding defective CIC W37A mutant fragment, enhanced the oligomer formation (Lasagna-Reeves, C.A., et al. (2015). eLlife. 4:e07558).

      Immunohistochemistry Analysis: A representative lot detected beta-sheet oligomer immunoreactivity in paraffin-embedded cerebellum and cortex sections of Atxn1154Q/+, but not wild-type, mice (Lasagna-Reeves, C.A., et al. (2015). eLlife. 4:e07558).
      Biological Information
      ImmunogenColloidal gold-conjugated Prp-G.
      CloneF11G3
      ConcentrationPlease refer to lot specific datasheet.
      HostMouse
      SpecificityClone F11G3 was raised against collodial gold particles coated with a synthetic peptide, Prp-G, whose sequence corresponds to an unstructured region of prion protein (Prp) with Met-to-Gly point mutations, as a beta-sheet oligomer mimetic (Guerrero-Muñoz, M.J., et al. (2013). ACS Chem. Neurosci. 4(12):1520-1523). Clone F11G3 recognizes oligomeric, but not monomeric or fibrillar, forms of Aβ42, α-syn, PrP, TDP-43, and polyQ Ataxin-1, as well as the misfolded oligomeric proteins in human AD brain samples (Lasagna-Reeves, C.A., et al. (2015). eLlife. 4:e07558; Guerrero-Muñoz, M.J., et al. (2014). Neurobiol. Dis.71:14-23).
      IsotypeIgMκ
      Species Reactivity
      • Human
      • Mouse
      Species Reactivity NoteHuman. Mouse. All species. Target conformation is not species-specific.
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • APP
      • PRNP
      • PRP
      • MAPT
      • TAU
      • SNCA
      • TARDBP
      • TDP43
      Purification MethodProtein A Purfied
      UniProt Number
      Molecular WeightVariable, depending on the sizes and the species of the oligomers formed.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blotting of oligomeric amyloid.

      Western Blotting Analysis: 2.0 µg/mL of this antibody detected 10 µg of oligomeric amyloid.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt.
      Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      MABN1839 04055977314977

      Documentation

      Anti-Amyloid-β (oligomer) Antibody, clone F11G3 (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Anti-Amyloid-β (oligomer) Antibody, clone F11G3 試験成績書（CoA）

      タイトルロット番号
      Anti-Amyloid-β (oligomer), clone -2822001 2822001
      Anti-Amyloid-β (oligomer), clone F11G3 - 3231936 3231936
      Anti-Amyloid-β (oligomer), clone F11G3 - 3419582 3419582
      Anti-Amyloid-β (oligomer), clone F11G3 - 3954778 3954778
      Anti-Amyloid-β (oligomer), clone F11G3 - 4045758 4045758
      Anti-Amyloid-β (oligomer), clone F11G3 -Q2642737 Q2642737
      Anti-Amyloid-β (oligomer), clone F11G3 Monoclonal Antibody 3013239

      カタログ

      タイトル
      Neuroscience Solutions for productive research

      関連製品＆アプリケーション

      Related Products

      カタログ番号 説明  
      AB5058 Anti-Prion Protein Antibody, NT, a.a. 78-97 価格＆在庫状況を表示
      MAB1562 Anti-Prion Protein Antibody, a.a. 109-112, clone 3F4 価格＆在庫状況を表示
      MAB5424 Anti-Prion Protein Antibody 価格＆在庫状況を表示
      MABN1186 Anti-Prion Protein Antibody, clone 12D6.1 価格＆在庫状況を表示

      カテゴリー

      Life Science Research > Antibodies and Assays > Primary Antibodies